홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Sodium Hydroxide → 4-((3-chlorophenyl)amino)-3-hydroxy-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide formate

HRID 528568
인쇄

반응식

HRID 528568 반응식
[Cl:1][C:2]1[CH:3]=[C:4]([N:8]2[C:12]3[CH:13]=[CH:14][C:15]([S:17]([N:20](CC4C=CC(OC)=CC=4OC)[C:21]4[S:22][CH:23]=[N:24][N:25]=4)(=[O:19])=[O:18])=[CH:16][C:11]=3[O:10][C:9]2=[O:37])[CH:5]=[CH:6][CH:7]=1.[OH-].[Na+].[NH4+].[Cl-]>CO>[CH:9]([OH:37])=[O:10].[Cl:1][C:2]1[CH:3]=[C:4]([NH:8][C:12]2[CH:13]=[CH:14][C:15]([S:17]([NH:20][C:21]3[S:22][CH:23]=[N:24][N:25]=3)(=[O:18])=[O:19])=[CH:16][C:11]=2[OH:10])[CH:5]=[CH:6][CH:7]=1
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 14798Sodium HydroxideHCID 25517Ammonium ChlorideHCID 897613473-(3-chlorophenyl)-N-(2,4-dimethoxybenzyl)-2-oxo-N-(1,3,4-thiadiazol-2-yl)-2,3-dihydrobenzo[d]oxazole-6-sulfonamide

생성물 1

HCID 897619394-((3-chlorophenyl)amino)-3-hydroxy-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide formate

시약·촉매·용매 1

HCID 887Methanol
용매

반응 조건

온도
80 °C

실험 절차

A sealable vial was charged with 3-(3-chlorophenyl)-N-(2,4-dimethoxybenzyl)-2-oxo-N-(1,3,4-thiadiazol-2-yl)-2,3-dihydrobenzo[d]oxazole-6-sulfonamide (38 mg, 0.068 mmol), and an aqueous solution of sodium hydroxide (2549 μL, 5.10 mmol) was added. The mixture was heated at 80° C. for 1 h, then poured into sat. aq. NH4Cl. The solution became heterogeneous, extracted with DCM, product did not go into organic layer, even after addition of brine. Aqueous layer was lyophilized to give product along with salts. The mixture was dissolved in MeOH and filtered to remove the majority of salts. The filtrate was concentrated onto Celite® (diatomaceous earth) and eluted through a pre-equilibrated C18 silica gel column (12 g) and eluted with a gradient of 95:5 1% formic acid in water: 1% formic acid in MeCN—10:90 1% formic acid in water: 1% formic acid in MeCN, followed by 100% IPA wash. The fractions containing desired product were concentrated to provide 4-((3-chlorophenyl)amino)-3-hydroxy-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide formate as a white amorphous solid. m/z (ESI) 383.1 (M+H)+.

후처리

  1. extractionextracted with DCM, product
  2. additioneven after addition of brine
  3. customto give product along with salts
  4. filtrationfiltered
  5. customto remove the majority of salts
  6. concentrationThe filtrate was concentrated onto Celite® (diatomaceous earth)
  7. washeluted through a pre-equilibrated C18 silica gel column (12 g)
  8. washeluted with a gradient of 95:5 1% formic acid in water
  9. washwash
  10. additionThe fractions containing desired product
  11. concentrationwere concentrated

출처 및 근거

ORD 기록
ord-e5c14b6bc9834eed8e5e9c499401401b
출처 데이터셋
uspto-grants-2016_05
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09346798B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트